Medico Remedies Limited Market Cap ($16.66 Million)
Market Cap & Net Worth: Medico Remedies Limited (MEDICO)
Medico Remedies Limited market cap. Medico Remedies Limited (NSE:MEDICO) has a market capitalization of $16.66 Million (Rs1.54 Billion) as of November 5, 2026. Listed on the NSE stock exchange, this India-based company holds position #25530 globally and #1412 in its home market, demonstrating a -9.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medico Remedies Limited's stock price Rs18.56 by its total outstanding shares 82984000 (82.98 Million). Also see MEDICO cash flow conversion for how efficiently the company converts equity into cash flow.
Medico Remedies Limited Market Cap History (2022–2026)
Medico Remedies Limited market cap history from 2022 to 2026. Data shows change from $58.49 Million to $16.66 Million (-5.79% CAGR). Check Medico Remedies Limited (MEDICO) stock price for real-time trading data and today's change.
Medico Remedies Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medico Remedies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Medico Remedies Limited net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.01x
Medico Remedies Limited's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.13x
Medico Remedies Limited's market cap is 0.13 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $58.49 Million | $1.21 Billion | $48.12 Million | 0.05x | 1.22x |
| 2023 | $75.21 Million | $1.40 Billion | $72.42 Million | 0.05x | 1.04x |
| 2024 | $49.31 Million | $1.45 Billion | $82.91 Million | 0.03x | 0.59x |
| 2025 | $45.41 Million | $1.51 Billion | $100.93 Million | 0.03x | 0.45x |
| 2026 | $16.66 Million | $2.06 Billion | $131.15 Million | 0.01x | 0.13x |
Competitor Companies of MEDICO by Market Capitalization
Companies near Medico Remedies Limited in the global market cap rankings as of November 5, 2026. Also see Medico Remedies Limited total assets for a full breakdown of the balance sheet.
Key companies related to Medico Remedies Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Medico Remedies Limited (2022–2026)
Market capitalization of Medico Remedies Limited from 2022 to today. Between 2022 and today, Medico Remedies Limited's market cap moved from $58.49 Million to $ 16.66 Million, with a yearly change of -5.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs16.66 Million | -63.32% |
| 2025 | Rs45.41 Million | -7.92% |
| 2024 | Rs49.31 Million | -34.43% |
| 2023 | Rs75.21 Million | +28.59% |
| 2022 | Rs58.49 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Medico Remedies Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.66 Million USD |
| MoneyControl | $16.66 Million USD |
| MarketWatch | $16.66 Million USD |
| marketcap.company | $16.66 Million USD |
| Reuters | $16.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more